Blair William & Co. IL lowered its position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 19.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,637 shares of the medical instruments supplier’s stock after selling 8,221 shares during the period. Blair William & Co. IL’s holdings in DENTSPLY SIRONA were worth $1,307,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of XRAY. First Eagle Investment Management LLC boosted its position in DENTSPLY SIRONA by 315.6% during the third quarter. First Eagle Investment Management LLC now owns 6,155,959 shares of the medical instruments supplier’s stock valued at $232,326,000 after purchasing an additional 4,674,605 shares in the last quarter. Orbimed Advisors LLC boosted its position in DENTSPLY SIRONA by 963.8% during the second quarter. Orbimed Advisors LLC now owns 2,393,500 shares of the medical instruments supplier’s stock valued at $104,763,000 after purchasing an additional 2,168,500 shares in the last quarter. Veritas Asset Management LLP boosted its position in DENTSPLY SIRONA by 18.2% during the third quarter. Veritas Asset Management LLP now owns 11,928,003 shares of the medical instruments supplier’s stock valued at $450,163,000 after purchasing an additional 1,835,402 shares in the last quarter. Nuance Investments LLC boosted its position in DENTSPLY SIRONA by 57.4% during the third quarter. Nuance Investments LLC now owns 3,423,095 shares of the medical instruments supplier’s stock valued at $129,228,000 after purchasing an additional 1,248,784 shares in the last quarter. Finally, Schroder Investment Management Group boosted its position in DENTSPLY SIRONA by 53.9% during the third quarter. Schroder Investment Management Group now owns 2,767,132 shares of the medical instruments supplier’s stock valued at $104,432,000 after purchasing an additional 969,409 shares in the last quarter. 96.21% of the stock is currently owned by institutional investors.
Shares of NASDAQ XRAY opened at $36.31 on Friday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.76 and a quick ratio of 1.14. The stock has a market capitalization of $8.19 billion, a price-to-earnings ratio of 13.65, a price-to-earnings-growth ratio of 2.24 and a beta of 1.18. DENTSPLY SIRONA Inc has a fifty-two week low of $33.93 and a fifty-two week high of $68.47.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 8th. The medical instruments supplier reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.46 by ($0.08). The business had revenue of $928.40 million during the quarter, compared to analyst estimates of $951.58 million. DENTSPLY SIRONA had a positive return on equity of 8.68% and a negative net margin of 41.97%. DENTSPLY SIRONA’s revenue was down 8.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.70 EPS. On average, equities analysts anticipate that DENTSPLY SIRONA Inc will post 1.97 earnings per share for the current year.
A number of equities research analysts recently weighed in on the company. HC Wainwright set a $40.00 price objective on DENTSPLY SIRONA and gave the company a “hold” rating in a research report on Friday, August 31st. ValuEngine raised DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 24th. BidaskClub raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Wednesday, November 21st. Goldman Sachs Group raised DENTSPLY SIRONA from a “sell” rating to a “buy” rating and set a $44.00 price objective on the stock in a research report on Friday, October 19th. Finally, Barrington Research reaffirmed a “hold” rating on shares of DENTSPLY SIRONA in a research report on Friday, November 9th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and six have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $51.50.
In other DENTSPLY SIRONA news, insider Markus Boehringer sold 7,373 shares of the firm’s stock in a transaction dated Monday, December 3rd. The stock was sold at an average price of $37.86, for a total value of $279,141.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.93% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY WARNING: “Blair William & Co. IL Cuts Stake in DENTSPLY SIRONA Inc (XRAY)” was reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://www.americanbankingnews.com/2018/12/08/blair-william-co-il-cuts-stake-in-dentsply-sirona-inc-xray.html.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Recommended Story: What are the reasons investors use put options?
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.